Why Aphria Inc. Is Soaring Over 15%

Aphria Inc. (TSX:APH) is soaring over 15% following its acquisition of Broken Coast Cannabis Inc. Should you be a long-term buyer? Let’s take a look.

What?

Medical cannabis producer Aphria Inc. (TSX:APH) is roaring over 15% higher in today’s trading session following its announcement that it has entered an agreement to acquire 100% of Broken Coast Cannabis Inc., a medical cannabis producer based in British Columbia, for a total cost of approximately $230 million.

So what?

In the press release, Aphria provided the following information about the acquisition:

“The transaction is expected to add incremental annual production of 10,500 kgs, a portion of which is market ready today, elevating Aphria’s forecast annual production to 230,000 kgs while also providing Aphria with geographic diversification, a cross-Canada distribution platform, and access to over 40,000 medical patients.”

Aphria’s chief executive officer Vic Neufield went on to state:

“Adding one of Canada’s most sought after premium brands represents a major triumph for Aphria and our shareholders and firmly establishes our position as a Canadian leader in premium indoor cannabis production … We look forward to learning from each other and bringing more Broken Coast cannabis to current medical patients and future adult recreational use consumers in Canada.”

Now what?

Aphria will pay the $230 million price tag with $10 million in cash and the rest in shares, and the transaction is expected to close by January 31, 2018, following the standard closing conditions. 

This is the third major deal Aphria has announced in the last two months, as it announced a $10 million investment in Hiku Brand Company Ltd. on December 21 and a supplier agreement with Shoppers Drug Mart on December 4; these deals have it positioned to be one of the industry’s leaders for the foreseeable future, and it has the potential to become one of the most profitable cannabis companies in the world following the legalization of adult recreational use of cannabis in Canada, which is expected to be announced at some point this year.

I think Aphria is the most well-positioned company to benefit from the growth of both medical and recreational cannabis, making it my favourite stock in the industry today. If you’re seeking exposure to this high-growth industry, take a closer look and consider beginning to scale in to long-term positions in Aphria over the next couple of trading sessions.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joseph Solitro has no position in any stocks mentioned.

More on Investing

think thought consider
Tech Stocks

Is CGI Stock a Buy Even With No Dividend Yield?

CGI stock may not have a dividend to speak of. But does that necessarily mean you should ignore this top…

Read more »

A robotic hand interacting with a visual AI touchscreen display.
Tech Stocks

Why Now Is the Time to Invest in Canadian AI Stocks

Are you looking for one of the most solid Canadian AI stocks out there? This one is probably your best…

Read more »

The letters AI glowing on a circuit board processor.
Tech Stocks

Why AI Stocks Should Be in Every Canadian Investor’s Portfolio

AI stocks continue to be one of the best options out there for long-term investing, especially when considering Canadian options.

Read more »

stock research, analyze data
Bank Stocks

Canadian Bank Stocks: Buy, Sell, or Hold?

There are opportunities and risks on the horizon for the Canadian banks.

Read more »

Young Boy with Jet Pack Dreams of Flying
Stock Market

Is Air Canada Stock a Good Buy After Its Q3 Results

Down almost 60% from all-time highs, Air Canada is an undervalued TSX stock that remains an enticing investment in November…

Read more »

cloud computing
Investing

Where to Invest $10,000 in November

Given their solid underlying businesses and healthy growth prospects, I expect these two defensive stocks to outperform uncertain outlook.

Read more »

coins jump into piggy bank
Retirement

Here’s the Average RRSP Balance at Age 44 for Canadians

Holding stocks like Alimentation Couche-Tard (TSX:ATD) in an RRSP is a good way to build your wealth.

Read more »

dividends can compound over time
Dividend Stocks

Want a 7% Yield? The 3 TSX Stocks to Buy Today

These TSX stocks are offering high yields of over 7%, making them attractive for investors seeking steady passive income.

Read more »